식물 유래 의약품 시장 : 유형별, 공급원별, 치료 용도별, 제형별, 최종사용자별, 투여 경로별 - 세계 예측(2025-2030년)

The Botanical Drug Market was valued at USD 3.75 billion in 2023, expected to reach USD 4.01 billion in 2024, and is projected to grow at a CAGR of 6.96%, to USD 6.01 billion by 2030.

Botanical drugs, defined as complex mixtures derived from plant-based sources, have been gaining traction due to their natural origin and therapeutic potential. These drugs encompass various forms, including tinctures, teas, and essential oils, focusing especially on standardizing extracts with medicinal properties. The necessity for botanical drugs stems from the rising consumer preference for natural, sustainable healthcare options coupled with increased acceptance by global regulatory bodies. They are primarily applied in treating chronic diseases, such as arthritis, cardiovascular ailments, and cancer, where conventional treatments may falter or present significant side effects. The scope of end-use includes pharmaceutical, nutraceutical, and personal care industries, benefitting from growing interests in traditional medicine and holistic health. Market insights reveal that key growth factors include heightened R&D investments, favorable regulations, and increased public awareness of plant-based health solutions. Latest opportunities lie in personalizing botanical therapies and expanding applications in integrative medicine practices. Recommendations to capitalize on these opportunities include fostering strategic partnerships for research, optimizing supply chains for sustainable sourcing, and engaging in public health education. However, limitations include complex regulatory frameworks, limited clinical data compared to synthetics, and challenges in maintaining product consistency due to natural variability. Additionally, supply chain disruptions and stringent patent laws can hinder market growth. The best areas for innovation involve improving extraction methods, developing standardized formulations, and leveraging biotechnological advancements to enhance therapeutic efficacy and safety profiles of botanical drugs. As the market is characterized by fragmentation with numerous small to mid-sized firms, opportunities abound for establishing niche leadership through targeted innovations and agile business strategies. Understanding consumer trends and investing in a scalable infrastructure is crucial for navigating the complex landscape of botanical drugs, while staying abreast of evolving regulatory standards can provide a competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Botanical Drug Market

The Botanical Drug Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Government initiatives and funding supporting the development of botanical drugs
  • Expansion of distribution channels and e-commerce platforms for botanical products
  • Adoption of advanced extraction and formulation technologies in botanical drug manufacturing
  • Significant investments by key market players in botanical drug research and commercialization
• Market Restraints
  • Limited clinical trial data and scientific validation on the efficacy and safety of botanical drugs
  • Intellectual property challenges and competition with synthetic drugs impede market growth
• Market Opportunities
  • Rising prevalence of chronic diseases increasing the adoption of botanical drugs for alternative treatment
  • Expansion of distribution channels including e-commerce platforms boosting market reach and accessibility
  • Development of personalized botanical medicine catering to individual health needs and preferences driving market growth
• Market Challenges
  • Limited scientific evidence and clinical trials to support botanical drug efficacy and safety claims hamper market growth
  • Supply chain disruptions and raw material scarcity affect production consistency in the botanical drug industry

Porter's Five Forces: A Strategic Tool for Navigating the Botanical Drug Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Botanical Drug Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Botanical Drug Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Botanical Drug Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Botanical Drug Market

A detailed market share analysis in the Botanical Drug Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Botanical Drug Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Botanical Drug Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Botanical Drug Market

A strategic analysis of the Botanical Drug Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Botanical Drug Market, highlighting leading vendors and their innovative profiles. These include Aphios Corporation, Botanix Pharmaceuticals Ltd, CanniMed Therapeutics Inc., Cardiol Therapeutics Inc., CV Sciences, Inc., Ecofibre Limited, EcoGen Laboratories, Emerald Health Pharmaceuticals, GB Sciences, Inc., GW Pharmaceuticals plc, HempMeds, InMed Pharmaceuticals Inc., Jazz Pharmaceuticals plc, Lexaria Bioscience Corp., MediPharm Labs Corp., PhytoTech Therapeutics Ltd., Tetra Bio-Pharma Inc., Tikun Olam Ltd., Veritas Pharma Inc., and Zynerba Pharmaceuticals, Inc..

Market Segmentation & Coverage

This research report categorizes the Botanical Drug Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Herbal Drugs, Nutraceuticals, and Phytomedicines. The Herbal Drugs is further studied across Multiple Herb Drugs and Single Herb Drugs.
• Based on Source, market is studied across Algae, Fungi, and Plants. The Plants is further studied across Barks, Leaves, Roots, and Seeds.
• Based on Therapeutic Application, market is studied across Cancer, Cardiovascular Diseases, Diabetes, Digestive Disorders, and Respiratory Disorders.
• Based on Formulation, market is studied across Capsules, Extracts, Ointments, Powders, and Tablets.
• Based on End User, market is studied across Clinics, Homecare, and Hospitals.
• Based on Route Of Administration, market is studied across Injectable, Oral, and Topical.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Government initiatives and funding supporting the development of botanical drugs
    • 5.1.1.2. Expansion of distribution channels and e-commerce platforms for botanical products
    • 5.1.1.3. Adoption of advanced extraction and formulation technologies in botanical drug manufacturing
    • 5.1.1.4. Significant investments by key market players in botanical drug research and commercialization
  • 5.1.2. Restraints
    • 5.1.2.1. Limited clinical trial data and scientific validation on the efficacy and safety of botanical drugs
    • 5.1.2.2. Intellectual property challenges and competition with synthetic drugs impede market growth
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising prevalence of chronic diseases increasing the adoption of botanical drugs for alternative treatment
    • 5.1.3.2. Expansion of distribution channels including e-commerce platforms boosting market reach and accessibility
    • 5.1.3.3. Development of personalized botanical medicine catering to individual health needs and preferences driving market growth
  • 5.1.4. Challenges
    • 5.1.4.1. Limited scientific evidence and clinical trials to support botanical drug efficacy and safety claims hamper market growth
    • 5.1.4.2. Supply chain disruptions and raw material scarcity affect production consistency in the botanical drug industry
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Botanical Drug Market, by Type

• 6.1. Introduction
• 6.2. Herbal Drugs
  • 6.2.1. Multiple Herb Drugs
  • 6.2.2. Single Herb Drugs
• 6.3. Nutraceuticals
• 6.4. Phytomedicines

7. Botanical Drug Market, by Source

• 7.1. Introduction
• 7.2. Algae
• 7.3. Fungi
• 7.4. Plants
  • 7.4.1. Barks
  • 7.4.2. Leaves
  • 7.4.3. Roots
  • 7.4.4. Seeds

8. Botanical Drug Market, by Therapeutic Application

• 8.1. Introduction
• 8.2. Cancer
• 8.3. Cardiovascular Diseases
• 8.4. Diabetes
• 8.5. Digestive Disorders
• 8.6. Respiratory Disorders

9. Botanical Drug Market, by Formulation

• 9.1. Introduction
• 9.2. Capsules
• 9.3. Extracts
• 9.4. Ointments
• 9.5. Powders
• 9.6. Tablets

10. Botanical Drug Market, by End User

• 10.1. Introduction
• 10.2. Clinics
• 10.3. Homecare
• 10.4. Hospitals

11. Botanical Drug Market, by Route Of Administration

• 11.1. Introduction
• 11.2. Injectable
• 11.3. Oral
• 11.4. Topical

12. Americas Botanical Drug Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Botanical Drug Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Botanical Drug Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aphios Corporation
• 2. Botanix Pharmaceuticals Ltd
• 3. CanniMed Therapeutics Inc.
• 4. Cardiol Therapeutics Inc.
• 5. CV Sciences, Inc.
• 6. Ecofibre Limited
• 7. EcoGen Laboratories
• 8. Emerald Health Pharmaceuticals
• 9. GB Sciences, Inc.
• 10. GW Pharmaceuticals plc
• 11. HempMeds
• 12. InMed Pharmaceuticals Inc.
• 13. Jazz Pharmaceuticals plc
• 14. Lexaria Bioscience Corp.
• 15. MediPharm Labs Corp.
• 16. PhytoTech Therapeutics Ltd.
• 17. Tetra Bio-Pharma Inc.
• 18. Tikun Olam Ltd.
• 19. Veritas Pharma Inc.
• 20. Zynerba Pharmaceuticals, Inc.